Replies to post #114362 on Biotech Values

[jbog]

exwannabe,

You are still putting the only 2 potential Copox products in the same hands.

I'd guess Teva would throw its hands up in the air and withdraw its T Enox application declaring they can't meet the FDA regulations.

Teva would certainly earn more money in the long run getting Momenta's portion of the Sandoz deal rather than competing against Sandoz.